A phase I study of ICT01-2588 for the treatment of Lung and prostate cancer.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2016
At a glance
- Drugs ICT01 2588 (Primary)
- Indications Lung cancer; Prostate cancer
- Focus Adverse reactions; First in man
- 27 Jul 2016 New trial record